A first-in-human study to investigate safety and tolerability of SAR446959 in participants with osteoarthritis of the knee
Phase 1
Recruiting
- Conditions
- Osteoarthritis
- Registration Number
- 2024-514015-96-00
- Lead Sponsor
- Sanofi-Aventis Recherche & Developpement
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing, recruiting
- Sex
- Not specified
- Target Recruitment
- 112
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Not specified
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
PAREXEL International GmbH
🇩🇪Berlin, Germany
PAREXEL International GmbH🇩🇪Berlin, GermanyCamila RinconSite contact+4930166340453camila.rincon@parexel.com